A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of Clopidogrel

Clinical trial NCT01263093 · COMPLETED

Trial details

NCT number: NCT01263093
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2010-12-01
Primary completion: 2011-03-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.